accredited investor lead

BTV Explores Investment Options in Life Sciences

On national TV Sat. May 8 & Sun. May 9, 2021 - BTV-Business Television explores life science investment opportunities including psychedelic-based therapies and home COVID-19 tests.

Discover Companies to Invest In - Click company name to watch their TV feature:

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) - BTV learns how this company is revolutionizing healthcare by using psychedelic molecules to address mental health disorders.

Lexaria Bioscience Corp. (CSE: LXX) (NASDAQ: LEXX) - A leading bioscience company whose patented technology, DehyraTECH, provides a faster and more effective drug delivery method.

StageZero Life Sciences Ltd. (TSX: SZLS) - BTV learns about this company's next generation test that can detect up to ten different cancers in one sample of blood.

NeonMind Biosciences (CSE: NEON) (OTC: NMDBF) - Obesity is one of the world's biggest health issues. BTV weighs in on this novel psychedelic treatment approach to tackle the issue.

Empower Clinics Inc. (CSE: CBDT) - Is providing body and mind wellness for over 200,000 patients through its US and Canadian clinics, a telemedicine platform, home COVID-19 test kits and a world-class medical diagnostics laboratory in Texas.


On air for over 20 years, BTV - Business Television, a half-hour investment TV show, features analysts and emerging companies on location. With Hosts, Taylor Thoen and Jessica Katrichak, BTV brings viewers investment opportunities.

TV BROADCAST NETWORKS and TIMES:
CANADA:

BNN Bloomberg - Saturday May 8 @ 8:00pm EST, Sunday May 9 @ 4:30pm EST
Bell Express Vu - Saturday May 8 @ 8:00pm EST, Sunday May 9 @ 4:30pm EST

US National TV:
Biz Television Network - Sun May 16 @ 8:30am EST

Suggest a Company to Feature!
Contact: (604) 664-7401 x3 info@b-tv.com
To receive news, click here to subscribe.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/83068

News Provided by Newsfile via QuoteMedia

The Conversation (0)
Lexaria Bioscience

Lexaria Bioscience

Overview

Lexaria Bioscience Corp. (NASDAQ:LEXX) is a biotechnology company focused on its proprietary drug delivery technology DehydraTECH™. The company has been granted 18 patents internationally and submitted over 60 patent applications. Operating on an out-licensing and royalty business model, the company generates most of its revenue from very high profit-margin royalties by licensing its patented DehydraTECH™ technology to other companies.

Lexaria is exploring several verticals for its DehydraTECH™ technology:

Keep reading...Show less

Out-Licensing Patented Biotechnologies

Latest Press Releases

Related News

×